The system to malignancy management presents notable differences between the US and Europe . Generally, US healthcare is characterized by a greater reliance on individual coverage , leading to https://joanqjan318873.activoblog.com/51589816/united-states-vs-trans-atlantic-malignancy-care-a-detailed-examination